FinancialCentre Reports – Expert suggests 3 Stocks to Watch This Week

London, UK — The economic market in every sector has been facing bearish trends that have caused investors to limit their investments, with some selling off their assets to avoid losing it all. The COVID-19 economic crisis has ended, but it has rooted fear in the hearts of investors and traders that the equity markets might face another recession, making them hold their investments.

The S&P 500 faced its 10th down week in the past 11 weeks. In previous weeks the SPX sectors closed their stock price around 10% below their recent highs. The Dow Jones Industrial Average encountered its first fall below 30,000 since Q1 of 2021.

The market volatility has caused the prices of stocks to fall, with other factors adding up to the market pressure. For instance, the interest rates have been increased by three-quarters of a percentage point by the U.S. Federal Reserve. With inflation rising to new heights, the central bank has no plans to give relief until the inflation problem is solved. The high-interest rates have forced investors or stock-owners to sell off their assets and stocks, causing the markets to fall harder.

The downfall of technology and cyclical stocks does not mean this trend will be followed for a long time. However, with growing inflation, rising interest rates, and Russia’s recent invasion of Ukraine, the markets are under pressure. According to Jessica Grey, a stocks expert at FinancialCentre, the economy does not follow constant trends and keeps changing.

Amid the downfall, we have listed the top 3 stocks you might consider investing in this week. They have great long-term potential, and regardless of facing a pandemic, they are doing great relative to other companies.

Top 3 Stocks to keep an eye on

  • Pfizer Inc. (PFE):

Pfizer Inc. is a multinational biopharmaceutical based in the U.S. It is a research-based company focused on manufacturing, developing, producing, marketing, and distributing biopharma products on a global scale, like medicines and vaccines for dermatology, cardiology, gastroenterology, cardiology, neurology, and many more. The company aims to maintain health and prevent and treat diseases. It works with local and national governments of different countries to cure diseases.

The company was established in 1849 with headquarters in Manhattan, New York City, U.S. The company’s shares are listed on NYSE under the ticker symbol PFE. Pfizer Inc. (PFE) has a current market capitalization of $273.36 Billion. The earnings per share (EPS) of the company is 4.43 and pays about a 1.60 (3.33%) dividend yield.

Pfizer developed a vaccine for COVID-19 that got approved by health authorities. This vaccine boosted the company’s sales. By April 2022, the company reported having made $32 billion from the contracts and $22 billion from the COVID pill. During only one year, the PFE shares have seen an excellent growth of about 22.04%, making it quite an attractive stock to add to your portfolio this week.

  • FedEx Corporation (FDX):

FedEx Corporation (FedEx) is a multinational company specializing in transportation, e-commerce, and several business services. The companies under FedEx operate independently. The company provides its services under four different segments. FedEx Express deals with the transportation of United States domestic products internationally. FedEx Ground offers small-package delivery services in the United States and Canada. FedEx Freight deals with less-than-truckload freight services. FedEx Services is focused on I.T., marketing, and customer support, providing tech support, billing, and collection services.

FedEx, formerly known as Federal Express Corporation and FDX Corporation for a while, was founded in 1971 with headquarters in Memphis, Tennessee, U.S. The shares of this company are listed on NYSE under the ticker symbol FDX. The current market capitalization of FedEx Corporation is 59.72B. The earnings per share (EPS) of FDX is 18.15 and pays about a 4.60 (2.00%) dividend yield. The price-earnings ratio (P/E) of the company is 12.70.

In the past week, the company’s share rose to 14%, covering the loss faced in the previous year. The company is expected to earn a profit of $24.49 billion in the Q4 of 2022, making it an even more attractive investment opportunity than the previous stock.

  • Coinbase Global Inc. (COIN):

Coinbase Global, Inc. is a known name in the crypto world. It provides a platform to exchange cryptocurrencies all over the world. Founded in the U.S., the company has employees who work from their homes, which is why it does not have a physical headquarters. Coinbase allows its clients to make financial accounts in the digital market to trade their assets in a secure ecosystem with increased liquidity.

Due to the COVID-19 economic recession, crypto markets have been experiencing a downfall, including, Coinbase. The company is predicted to experience an increased sell-off in the coming week because of Bitcoin’s price fall. The unpredicted market trends led to the Coinbase stock price closing of $51.22 last week.

The company, Coinbase was established in 2012. It has no specific headquarters and serves 100+ countries; however, it is based in Wilmington, Delaware. The shares of this company are listed on NASDAQ under the ticker symbol COIN. The current market capitalization of this company is $12.51 Billion. Coinbase Global has earnings per share (EPS) of 10.42 with a price-earnings ratio (P/E) of 5.52.

The trading volume of Coinbase is the highest among the crypto exchanges in the States, making it the largest platform in the U.S., which is also a good sign for considering investing in it. Also, the downtrend of the crypto market is not supposed to be followed forever, and Coinbase, a crypto exchange, has tremendous growth potential. It could be an incredible opportunity for investors to earn a profit on long-term investment plans.

Disclaimer: Our content is intended to be used for informational purposes only. It is very important to do your own research before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, or independently research and verify, any information that you find in this article and wish to rely upon, whether for the purpose of making an investment decision or otherwise.

Media contact: